Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Beacon Hill Medical Pharmacy, P.C.

Beacon Hill Medical Pharmacy, P.C. Recalls

All product recalls associated with Beacon Hill Medical Pharmacy, P.C..

Get alerts for this brand

Recall Summary

Total Recalls

86

Past Year

0

Class I (Serious)

0

Most Recent

Jul 2013

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 86 recalls

Magnesium Sulfate Injectable (Beacon Hill) – Sterility Doubt (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Tri-Mix Injectable (Beacon Hill) – Sterility Concern (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Estriol Injectable Solution (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Previous

12 3...5

Page 1 of 5Next

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Dual-Testosterone Injectable Solution (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Triamcinolone Acetonide Injection (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Oxytocin Injectable (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Alprostadil Injectable Solution (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Selenium Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Chromium Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Sermorelin Acetate Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Phosphatidylcholine Injectable (Beacon Hill) – Sterility Issue (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Dexpanthenol Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Lipoic Acid Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Glutathione (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Glutathione/Lidocaine (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Zinc Sulfate Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Glycyrrhizic Acid (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Calcium EDTA (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Prog/Test CYP (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Hydrogen Peroxide Injectable (Beacon Hill) – Sterility Risk (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.